Depressive Disorder, Major: all 2,805 studies

Page 24 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.

• Lexapro®'s Efficacy After Dose Escalation in Remission StudyCompletedNCT01594866Phase 4
• ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain StimulatorsCompletedNCT01590862Not applicable
• Electronic-Measurement Based Care for Major Depressive DisorderWithdrawnNCT01583998Not applicable
• Complex Dynamic Systems in Mood DisordersCompletedNCT01583569
• Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E TrialCompletedNCT01583400Not applicable
• A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety SymptomsCompletedNCT01582815Phase 2
• Study of Technology-assisted Treatment of Adolescent DepressionCompletedNCT01582581Not applicable
• Potential Use Of Brain Network Activation Analysis to Diagnose Major DepressionTerminatedNCT01579942
• Study of Ketamine as an Antidepressant in Major Depressive DisorderStatus unknownNCT01573741Phase 1/2
• Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01573598Phase 4
• Mediators and Moderators of Treatment Outcome in Recent-Onset PsychosisCompletedNCT01570972Not applicable
• Deep Brain Stimulation of Nucleus Accumbens for Chronic and Resistant Major Depressive DisorderCompletedNCT01569711
• Brain Imaging, Genetics and Treatment for Major DepressionWithdrawnNCT01568684Phase 1
• Major Depressive Disorder - Understanding The Link Between The Brain And The HeartCompletedNCT01568307Phase 4
• Improving Depression Care for Elders: Coordinating CenterCompletedNCT01561105Not applicable
• Electroconvulsive Therapy (ECT) for Elderly Patients With Major DepressionCompletedNCT01559324Phase 4
• Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six WeeksCompletedNCT01557712Phase 3
• Pilot Study of Behavioral Activation for Prolonged GriefCompletedNCT01556048Phase 1
• A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy VolunteersCompletedNCT01546051Phase 1
• Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive DisorderCompletedNCT01541475Phase 4
• Meditation to Reduce Caregiver StressCompletedNCT01537679Not applicable
• Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder PatientsCompletedNCT01533285Early Phase 1
• Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol DependenceCompletedNCT01528748
• Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian HospitalCompletedNCT01526395Not applicable
• Treatment of Major Depressive Disorder Post Stroke With Transcranial Direct Current StimulationCompletedNCT01525524Phase 2
• Acceptance and Commitment Therapy Versus Cognitive Therapy for the Treatment of Major Depressive DisorderCompletedNCT01517503Not applicable
• Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive DisorderCompletedNCT01515215Not applicable
• Changes in Cerebral Glucose Metabolism After Electroconvulsive Therapy (ECT)CompletedNCT01514435Not applicable
• ON/OFF Stimulation and Impulsivity in Patients With Deep Brain StimulatorsWithdrawnNCT01506206
• Effect of Antidepressants on White Matter StructureStatus unknownNCT01492621Phase 4
• Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive DisorderStatus unknownNCT01488266Not applicable
• Early Intervention for Youth at Risk for Bipolar DisorderCompletedNCT01483391Not applicable
• Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)Status unknownNCT01483053Phase 4
• A Positron Emission Topographic (PET) Study on Depression Patient With ElectroacupunctureCompletedNCT01479920Not applicable
• Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical FeaturesCompletedNCT01477931Phase 4
• Multimodal Assessment of Neurobiological Markers for Psychiatric DisordersCompletedNCT01477203Phase 4
• Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar DepressionStatus unknownNCT01473615Not applicable
• Event Related Potentials in Borderline Personality Disorder and Major DepressionTerminatedNCT01469663
• Neurocognition and Work Productivity in Major Depressive Disorder (MDD)CompletedNCT01468610Not applicable
• Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive DisorderStatus unknownNCT01467804Not applicable
• Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major DepressionTerminatedNCT01465165
• Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive DisorderStatus unknownNCT01460212Phase 4
• Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early ImprovementCompletedNCT01458626Phase 4
• ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentCompletedNCT01457677Phase 2
• Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive DisorderCompletedNCT01454635Not applicable
• Transcranial Direct Current Stimulation as an Augmenting Intervention for Major DepressionStatus unknownNCT01450150Phase 2/3
• General Practice Research Database Seroquel XR Safety StudyCompletedNCT01447082
• Badalona Major Depressive Disorder Database StudyCompletedNCT01446692
• A Stepped Care Model of Adolescent Depression Treatment in Primary CareCompletedNCT01443715Phase 2/3
• Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release TabletCompletedNCT01443208Phase 1
• Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and DepressionCompletedNCT01441258Not applicable
• An Open Label Study of the Genecept™ Assay in Treatment Resistant DepressionWithdrawnNCT01438242Not applicable
• MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant TherapyCompletedNCT01437657Phase 2
• Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant DepressionCompletedNCT01431001Not applicable
• Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity DisorderCompletedNCT01430767
• Aripiprazole for the Augmentation of Antidepressant TherapyCompletedNCT01429831Phase 4
• Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major DepressionCompletedNCT01428804Phase 2
• A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive DisorderCompletedNCT01427439
• Phenotype Depression StudyCompletedNCT01426997
• Exploring Biomarkers for DepressionCompletedNCT01424111
• Major Depressive Disorder With Mixed FeaturesWithdrawnNCT01423240Phase 3
• The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive DisorderStatus unknownNCT01418638
• Lithium Versus Paroxetine in Major DepressionWithdrawnNCT01416220Phase 4
• Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive DisorderCompletedNCT01413932Phase 1/2
• Neural Predictors and Longitudinal Neural Correlates of Deep Transcranial Magnetic Stimulation for Treating Major DepressionCompletedNCT01409317Phase 2/3
• Effectiveness of Deep Transcranial Magnetic Stimulation in DepressionCompletedNCT01409304Phase 2/3
• Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in Major DepressionCompletedNCT01399671Not applicable
• Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate ResponseCompletedNCT01397903
• Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive DisorderCompletedNCT01395147Phase 3
• Treatment Resistant Geriatric Depression in Primary CareCompletedNCT01392287Phase 1
• Inflammatory Markers and Cognitive Function in Major DepressionStatus unknownNCT01391221Phase 4
• The Influence of the Menstrual Cycle on Lithium and Sertraline Blood LevelsCompletedNCT01385709
• ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDDCompletedNCT01381107Phase 1/2
• Safety and Pharmacodynamic Study of ABT-436 in Major Depressive DisorderCompletedNCT01380704Phase 1
• The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription BehavioursCompletedNCT01377896
• Electroencephalography (EEG) Signal ProcessingStatus unknownNCT01369290
• Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)CompletedNCT01361815Not applicable
• Neurophysiologic Monitoring of Antidepressant TreatmentCompletedNCT01360190Phase 4
• Healthy Mood Internet Intervention Research ProjectCompletedNCT01358487Not applicable
• The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude SlopeStatus unknownNCT01357967Phase 4
• The Study of Serum Melatonin Rhythm Levels in Patients With Major Depressive DisorderCompletedNCT01357083
• Health Care Management for the Elderly in Community Through ScreeningCompletedNCT01347138Not applicable
• A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)CompletedNCT01344733
• African American Depression Intervention Trial (AADI)CompletedNCT01342536Phase 3
• Pioglitazone and Quetiapine XR Pharmacogenetic StudyCompletedNCT01342380
• PHARMO Institute Seroquel Safety StudyCompletedNCT01342120
• Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive DisorderCompletedNCT01330485Not applicable
• Internet-Based Depression Screening for College StudentsCompletedNCT01326793Not applicable
• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)CompletedNCT01318434Phase 2/3
• Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive DisorderWithdrawnNCT01313403Not applicable
• Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesTerminatedNCT01310140
• Comparison of Tianeptine Versus Escitalopram Patients Major Depressive DisorderCompletedNCT01309776Phase 4
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
• The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed EldersCompletedNCT01305889Not applicable
• Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)CompletedNCT01284218
• Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
• Safety and Efficacy of RX-10100 to Treat Major Depressive DisorderCompletedNCT01273376Phase 2
• DBS in Treatment Resistant Major DepressionStatus unknownNCT01268137Phase 3
• Tai Chi Training for Treating Depressed Chinese AmericansCompletedNCT01263730Not applicable
• A Study of LY2940094 in Major Depressive DisorderCompletedNCT01263236Phase 1

← Depressive Disorder, Major overview